By Professor Andrew Lloyd

Preprints

Walker MR; Leung P; Keoshkerian E; Pirozyan MR; Lloyd AR; Luciani F; Bull RA, 2024, Temporal dynamics of viral fitness and the adaptive immune response in HCV infection, http://dx.doi.org/10.1101/2024.09.07.611784

Adhikari A; Abayasingam A; A NB; Kim HN; Lord M; Agapiou D; Maher L; Rodrigo C; Lloyd A; Bull R; Tedla N, 2023, Characterisation of antibody dependent cellular phagocytosis in patients infected with Hepatitis C virus with different clinical outcomes, http://dx.doi.org/10.22541/au.168992839.95818489/v1

Kwon JA; Bretaña NA; Kronfli N; Dussault C; Grant L; Galouzis J; Hoey W; Blogg J; Lloyd AR; Gray RT, 2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, http://dx.doi.org/10.1101/2023.05.08.23289690

Baird S; Ashley CL; Marsh-Wakefield F; Alca S; Ashhurst TM; Ferguson AL; Lukeman H; Counoupas C; Post JJ; Konecny P; Bartlett A; Martinello M; Bull RA; Lloyd A; Grey A; Hutchings O; Palendira U; Britton WJ; Steain M; Triccas JA, 2023, A unique cytotoxic CD4⁺T cells signature defines critical COVID-19, http://dx.doi.org/10.1101/2023.02.17.23286059

Wyller V; Selvakumar J; Havdal L; Drevvatne M; Brodwall E; Berven L; Stiansen-Sonerud T; Einvik G; Leegaard T; Tjade T; Michelsen A; Mollnes T; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler C; Cvejic E; Lloyd A, 2022, Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study, http://dx.doi.org/10.21203/rs.3.rs-2021203/v1

Cai C; Samir J; Pirozyan M; Adikari T; Gupta M; Leung P; Hughes B; Van der Byl W; Rizzetto S; Elthala A; Keoshkerian E; Palgen J-L; Peters T; Nguyen T; Louie R; Kedzierska K; Gaudieri S; Bull R; Lloyd A; Luciani F, 2021, Single cell multi-omics reveals early elevated function and multiple fates within human progenitor exhausted CD8⁺ T cells, http://dx.doi.org/10.1101/2021.09.09.459584

Bull R; Abayasingam A; Balachandran H; Agapiou D; Rodrigo C; Keoshkerian E; Li H; Brasher N; Christ D; Rouet R; Burnett D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Brilot F; Mina M; Post J; Hudson B; Gilroy N; Dwyer D; Sasson S; Tea F; Pilli D; Tedla N; Lloyd A; Martinello M, 2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, http://dx.doi.org/10.21203/rs.3.rs-92527/v1

Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267510

Shih STF; Cheng Q; Carson J; Valerio H; Sheehan Y; Gray RT; Cunningham EB; Kwon J; Lloyd AR; Dore GJ; Wiseman V; Grebely J, Optimizing Point-of-Care Testing Strategies for Diagnosis and Treatment of Hepatitis C Virus Infection in Australia: A Model-Based Cost-Effectiveness Analysis, http://dx.doi.org/10.2139/ssrn.4267527

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Group S-CS, Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study, http://dx.doi.org/10.2139/ssrn.3709824

Back to profile page